Earnings · China A-shares
Zhejiang Hisun Pharmaceutical Co., Ltd. Class A (600267) earnings
Zhejiang Hisun Pharmaceutical Co., Ltd. Class A published its Q3 report on 2026-10-27: net profit +148.56% year on year, +100.11% excluding one-off items. Wave Radar's earnings-quality score is 82 of 100 (Sound). The stock moved -4.78% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-27
- Period end
- 2026-09-30
- Net profit YoY
- +148.56%
- Excl. one-offs YoY
- +100.11%
- Net profit QoQ
- +81.36%
- Result
- Great
- Quality score
- 82
- Quality
- Sound
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | -1.47% | — |
| 3 days | -4.78% | — |
| 7 days | +1.69% | — |
| 14 days | -5.66% | — |
Report history
Over the last 8 reports, net profit grew year on year in 4 of them. The stock rose in the 3 trading days after 2 of 8 reports (average -1.06%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-28 | ¥1.15B | +148.56% | +100.11% | -17.70% | 0.99 | 12.67% | -4.78% | — | — |
| 2026 interim report | 2026-08-26 | ¥636.48M | +112.82% | +59.79% | -14.76% | 0.55 | 7.20% | -0.65% | -7.49% | -0.50% |
| 2026 Q1 report | 2026-04-28 | ¥355.69M | +83.13% | +29.43% | -9.17% | 0.31 | 4.05% | -2.83% | -17.60% | -16.97% |
| 2025 annual report | 2026-04-08 | ¥540.71M | -10.06% | +36.11% | +2.03% | 0.46 | 6.41% | -3.48% | +0.09% | -9.32% |
| 2025 Q3 report | 2025-10-28 | ¥460.93M | -10.55% | +41.96% | +0.61% | 0.40 | 5.47% | +4.19% | +0.29% | +3.66% |
| 2025 interim report | 2025-08-26 | ¥299.07M | -31.29% | +23.92% | +0.13% | 0.26 | 3.56% | -5.50% | -10.31% | -11.98% |
| 2025 Q1 report | 2025-04-17 | ¥194.23M | -21.85% | +36.94% | -3.48% | 0.17 | 2.30% | -0.89% | +4.56% | +2.20% |
| 2024 annual report | 2025-03-29 | ¥601.18M | +745.24% | +505.18% | +2.86% | 0.52 | 7.43% | +5.44% | +0.68% | +2.24% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.